Essex LLC’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$504K Buy
2,284
+1
+0% +$277 0.08% 113
2026
Q1
$674K Buy
2,283
+3
+0.1% +$891 0.12% 97
2025
Q4
$623K Buy
2,280
+45
+2% +$12.2K 0.11% 104
2025
Q3
$604K Buy
2,235
+645
+41% +$175K 0.11% 105
2025
Q2
$438K Buy
1,590
+1
+0.1% +$272 0.09% 116
2025
Q1
$422K Sell
1,589
-52
-3% -$12.8K 0.09% 110
2024
Q4
$381K Sell
1,641
-4
-0.2% -$920 0.08% 116
2024
Q3
$363K Sell
1,645
-5
-0.3% -$1.03K 0.07% 120
2024
Q2
$324K Buy
1,650
+1
+0.1% +$207 0.07% 122
2024
Q1
$355K Buy
1,649
+52
+3% +$10.9K 0.08% 113
2023
Q4
$336K Sell
1,597
-328
-17% -$70K 0.08% 117
2023
Q3
$385K Buy
+1,925
New +$383K 0.11% 111

Other funds holding CME

Essex LLC's CME Position: Q2 2026 in Review

Essex LLC increased its CME Group (CME) stake by 0.04% in Q2 2026, buying an estimated $277 and bringing the position to 2,284 shares worth $504K. The position accounts for 0.08% of the portfolio, ranked #113.

Essex LLC first reported a position in CME in Q3 2023 and has held it in 12 quarters since. The position peaked at $674K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Essex LLC held 2,284 shares of CME Group worth $504K as of Q2 2026.
  • Essex LLC bought 1 CME Group share in Q2 2026, an estimated $277.
  • CME Group made up 0.08% of Essex LLC's portfolio in Q2 2026, its #113 holding.
  • Essex LLC first reported a position in CME Group in Q3 2023 and has held it in 12 quarters since.
  • Essex LLC's CME Group position peaked at $674K in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Essex LLC's 13F filing for Q2 2026, filed 24 Jul 2026.